Novartis sells U.S. generics assets to India’s bargain-hunting Aurobindo

New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India’s Aurobindo Pharma Ltd for up to $1 billion.

…read more

Source:: Reuters – Business News